WinSanTor
Phase 3WinSanTor is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy and HIV-induced peripheral neuropathy.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
WinSanTor is a clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy and HIV-induced peripheral neuropathy.
Small Molecules